Summary
Plasma insulin concentrations of insulin-treated diabetic patients must be measured after removal of insulin antibodies, usually by precipitation with polyethylene glycol (PEG). Details of the procedure vary between laboratories; commonly, frozen plasma is thawed and incubated at 37 °C to restore a presumed equilibrium between free and antibody bound insulin before extraction. The present study was designed to investigate methodological factors that could affect the measured free insulin concentration. In normal subjects PEG extraction of globulins did not disturb measurement of insulin concentrations, whether carried out after incubation for 2 h at 37 °C, or storage at -20 °C, in either order. Freezing or incubation of PEG extracts of plasma from insulin-treated patients also failed to disturb the measured concentrations of free insulin. When plasma from patients was incubated for 2 h after storage, a marked scatter (51–272%) of measured results occurred when compared to bedside extraction. This problem was not overcome by buffering with HEPES or storage at a lower temperature (-40 °C). Incubation at 0 °C also severely disturbed the apparent concentrations. Incubation of plasma before extraction and freezing also disturbed the measured result, a problem not corrected by maintaining near physiological pH. Total insulin concentrations measured on acid extracts were not disturbed by any of these manoeuvres. The temperature of centrifugation of blood at the time of venepuncture did not influence the result. Furthermore, when insulin concentrations were rising or falling similar percentage changes were seen over a 30-min incubation of plasma before extraction on the day of venepuncture, suggesting that equilibrium between free and bound insulin is maintained in vivo. We suggest that, for accurate estimation of free insulin concentrations in insulin-treated diabetic patients, immediate centrifugation of blood and extraction of insulin antibodies is mandatory.
Article PDF
Similar content being viewed by others
References
Berson SA, Yalow RS (1964) The present state of insulin antagonists in plasma. Diabetes 13: 247–259
Nakagawa S, Nakayama H, Sasaki T, Yoshino K, Yu YY, Shinozaki K, Aoki S, Mashimo K (1973) A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes 22: 590–600
Heding LG (1969) Determination of free and antibody-bound insulin in insulin treated diabetic patients. Horm Metab Res 1: 145–146
Asplin CM, Goldie DJ, Hartog M (1977) The measurement of serum free insulin by steady-state gel filtration. Clin Chim Acta 75: 393–399
Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH (1977) Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26: 22–29
Desbuquois B, Auerbach GD (1971) Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassay. J Clin Endocrinol 33: 732–738
Goldman J, Baldwin D, Pugh W, Rubenstein AH (1978) Equilibrium binding assay and kinetic characterisation of insulin antibodies. Diabetes 27: 653–660
Hales CN, Randle PJ (1963) Immunoassay of insulin with an insulin-antibody precipitate. Biochem J 88: 137–146
Soeldner J, Slone D (1965) Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes 14: 771–779
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Reeves WG, Kelly U (1980) An immunochemical method for the quantitation of insulin antibodies. J Immunol Methods 34: 329–338
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hanning, I., Home, P.D. & Alberti, K.G.M.M. Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodies. Diabetologia 28, 831–835 (1985). https://doi.org/10.1007/BF00291073
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00291073